Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry

Translational Research

Volumn 179, Issue , 2017, Pages 223-244

  Sandhu, Kiran V ^a   Sherwin, Eoin ^a   Schellekens, Harriët ^a,b   Stanton, Catherine ^a,b,c   Dinan, Timothy G ^a,b   Cryan, John F ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c TEAGASC FOOD RESEARCH CENTRE   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CARBOHYDRATE; NEUROTRANSMITTER; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYPHENOL; PROTEIN; SHORT CHAIN FATTY ACID; VITAMIN;

ADULTHOOD; ANXIETY; ATTENTION DEFICIT DISORDER; AUTISM; BIRTH; BRAIN; CARDIOVASCULAR SYSTEM; DEPRESSION; DIET; ENTEROENDOCRINE CELL; FEEDING; HEALTH STATUS; HUMAN; IMMUNE SYSTEM; INTESTINE FLORA; MEDITERRANEAN DIET; NEUROPSYCHIATRY; NUTRITIONAL STATUS; PRIORITY JOURNAL; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; WEANING; WESTERN DIET; AGE; GASTROINTESTINAL TRACT; METABOLISM; MICROBIOLOGY; MICROFLORA;

AGE FACTORS; BRAIN; DIET; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; MICROBIOTA; NEUROPSYCHIATRY;

EID: 85006096898     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2016.10.002     Document Type: Review

References (302)

1. 1 Sarris, J., Logan, A.C., Akbaraly, T.N., et al. Nutritional medicine as mainstream psychiatry. Lancet Psychiatry 2 (2015), 271–274.
2. 2 David, L.A., Maurice, C.F., Carmody, R.N., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
3. 3 Macdonald, T.T., Monteleone, G., Immunity, inflammation, and allergy in the gut. Science 307 (2005), 1920–1925.
4. 4 Ley, R.E., Bäckhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., Gordon, J.I., Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 102 (2005), 11070–11075.
5. 5 Steer, T., Carpenter, H., Tuohy, K., Gibson, G.R., Perspectives on the role of the human gut microbiota and its modulation by pro- and prebiotics. Nutr Res Rev 13 (2000), 229–254.
6. 6 Bäckhed, F., Ding, H., Wang, T., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101 (2004), 15718–15723.
7. 7 Cryan, J.F., O'Mahony, S.M., The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil 23 (2011), 187–192.
8. 8 Cryan, J.F., Dinan, T.G., More than a gut feeling: the microbiota regulates neurodevelopment and behavior. Neuropsychopharmacology 40 (2015), 241–242.
9. 9 Wang, Y., Kasper, L.H., The role of microbiome in central nervous system disorders. Brain Behav Immun 38 (2014), 1–12.
10. 10 Mulle, J.G., Sharp, W.G., Cubells, J.F., The gut microbiome: a new frontier in autism research. Curr Psychiatry Rep, 15, 2013, 337.
11. 11 Kelly, J.R., Borre, Y., O'Brien, C., et al. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res 82 (2016), 109–118.
12. 12 Jiang, H., Ling, Z., Zhang, Y., et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun 48 (2015), 186–194.
13. 13 Ridler, C., Gut microbiota: gut bacteria affect post-ischaemic inflammation in stroke by modulating intestinal T cells. Nat Rev Gastroenterol Hepatol, 13, 2016, 250.
14. 14 Dinan, T.G., Borre, Y.E., Cryan, J.F., Genomics of schizophrenia: time to consider the gut microbiome?. Mol Psychiatry 19 (2014), 1252–1257.
15. 15 De Filippo, C., Cavalieri, D., Di Paola, M., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107 (2010), 14691–14696.
16. 16 Cryan, J.F., Dinan, T.G., Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 10 (2012), 701–712.
17. 17 Borre, Y.E., Moloney, R.D., Clarke, G., Dinan, T.G., Cryan, J.F., The impact of microbiota on brain and behavior: mechanisms & therapeutic potential. Adv Exp Med Biol 817 (2014), 373–403.
18. 18 Goodrich, J.K., Davenport, E.R., Waters, J.L., Clark, A.G., Ley, R.E., Cross-species comparisons of host genetic associations with the microbiome. Science 352 (2016), 532–535.
19. 19 Kovatcheva-Datchary, P., Arora, T., Nutrition, the gut microbiome and the metabolic syndrome. Best Pract Res Clin Gastroenterol 27 (2013), 59–72.
20. 20 Flint, H.J., Scott, K.P., Louis, P., Duncan, S.H., The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 9 (2012), 577–589.
21. 21 Kurokawa, K., Itoh, T., Kuwahara, T., et al. Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res 14 (2007), 169–181.
22. 22 Grześkowiak, Ł., Collado, M.C., Mangani, C., et al. Distinct gut microbiota in southeastern African and northern European infants. J Pediatr Gastroenterol Nutr 54 (2012), 812–816.
23. 23 Mayer, E.A., Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 12 (2011), 453–466.
24. 24 Collins, S.M., Bercik, P., Gut microbiota: intestinal bacteria influence brain activity in healthy humans. Nat Rev Gastroenterol Hepatol 10 (2013), 326–327.
25. 25 Foster, J.A., McVey Neufeld, K.A., Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 36 (2013), 305–312.
26. 26 Furness, J.B., Rivera, L.R., Cho, H.J., Bravo, D.M., Callaghan, B., The gut as a sensory organ. Nat Rev Gastroenterol Hepatol 10 (2013), 729–740.
27. 27 Rinaman, L., Visceral sensory inputs to the endocrine hypothalamus. Front Neuroendocrinol 28 (2007), 50–60.
28. 28 Scarlett, J.M., Schwartz, M.W., Gut-brain mechanisms controlling glucose homeostasis. F1000Prime Rep, 7, 2015, 12.
29. 29 Forsythe, P., Sudo, N., Dinan, T., Taylor, V.H., Bienenstock, J., Mood and gut feelings. Brain Behav Immun 24 (2010), 9–16.
30. 30 Stilling, R.M., van de Wouw, M., Clarke, G., et al. The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis?. Neurochem Int 99 (2016), 110–132.
31. 31 Chiang, J.Y., Bile acid metabolism and signaling. Compr Physiol 3 (2013), 1191–1212.
32. 32 Bravo, J.A., Forsythe, P., Chew, M.V., et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 108 (2011), 16050–16055.
33. 33 Bercik, P., Park, A.J., Sinclair, D., et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 23 (2011), 1132–1139.
34. 34 Latorre, R., Sternini, C., De Giorgio, R., Greenwood-Van Meerveld, B., 2015 Enteroendocrine cells: a review of their role in brain-gut communication. Neurogastroenterol Motil 28 (2016), 620–630.
35. 35 Romijn, J.A., Corssmit, E.P., Havekes, L.M., Pijl, H., Gut-brain axis. Curr Opin Clin Nutr Metab Care 11 (2008), 518–521.
36. 36 Batterham, R.L., Cowley, M.A., Small, C.J., et al. Gut hormone PYY(3–36) physiologically inhibits food intake. Nature 418 (2002), 650–654.
37. 37 Koda, S., Date, Y., Murakami, N., et al. The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 146 (2005), 2369–2375.
38. 38 Cani, P.D., Everard, A., Duparc, T., Gut microbiota, enteroendocrine functions and metabolism. Curr Opin Pharmacol 13 (2013), 935–940.
39. 39 Egerod, K.L., Engelstoft, M.S., Grunddal, K.V., et al. A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin. Endocrinology 153 (2012), 5782–5795.
40. 40 Whited, K.L., Thao, D., Lloyd, K.C., Kopin, A.S., Raybould, H.E., Targeted disruption of the murine CCK1 receptor gene reduces intestinal lipid-induced feedback inhibition of gastric function. Am J Physiol Gastrointest Liver Physiol 291 (2006), G156–G162.
41. 41 Kimura, I., Inoue, D., Hirano, K., Tsujimoto, G., The SCFA receptor GPR43 and energy metabolism. Front Endocrinol (Lausanne), 5, 2014, 85.
42. 42 Samuel, B.S., Shaito, A., Motoike, T., et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A 105 (2008), 16767–16772.
43. 43 Tolhurst, G., Heffron, H., Lam, Y.S., et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61 (2012), 364–371.
44. 44 Ganapathy, V., Thangaraju, M., Prasad, P.D., Martin, P.M., Singh, N., Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Curr Opin Pharmacol 13 (2013), 869–874.
45. 45 Marchiando, A.M., Graham, W.V., Turner, J.R., Epithelial barriers in homeostasis and disease. Annu Rev Pathol 5 (2010), 119–144.
46. 46 Belkaid, Y., Hand, T., Role of the microbiota in immunity and inflammation. Cell 157 (2014), 121–141.
47. 47 McGuckin, M.A., Linden, S.K., Sutton, P., Florin, T.H., Mucin dynamics and enteric pathogens. Nat Rev Microbiol 9 (2011), 265–278.
48. 48 Cash, H.L., Whitham, C.V., Behrendt, C.L., Hooper, L.V., Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313 (2006), 1126–1130.
49. 49 Round, J.L., Mazmanian, S.K., The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 95 (2009), 313–323.
50. 50 Hooper, L.V., Macpherson, A.J., Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 10 (2010), 159–169.
51. 51 Pamer, E.G., Immune responses to commensal and environmental microbes. Nat Immunol 8 (2007), 1173–1178.
52. 52 Macpherson, A.J., Uhr, T., Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303 (2004), 1662–1665.
53. 53 Bengmark, S., Gut microbiota, immune development and function. Pharmacol Res 69 (2013), 87–113.
54. 54 Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9 (2008), 46–56.
55. 55 Lawson, M.A., Parrott, J.M., McCusker, R.H., Dantzer, R., Kelley, K.W., O'Connor, J.C., Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors. J Neuroinflammation, 10, 2013, 87.
56. 56 Erny, D., Hrabě de Angelis, A.L., Jaitin, D., et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 18 (2015), 965–977.
57. 57 Kau, A.L., Ahern, P.P., Griffin, N.W., et al. Human nutrition, the gut microbiome and the immune system. Nature 474 (2011), 327–336.
58. 58 Stilling, R.M., Dinan, T.G., Cryan, J.F., Microbial genes, brain & behaviour - epigenetic regulation of the gut-brain axis. Genes Brain Behav 13 (2014), 69–86.
59. 59 Hullar, M.A., Fu, B.C., Diet, the gut microbiome, and epigenetics. Cancer J 20 (2014), 170–175.
60. 60 Stilling, R.M., Bordenstein, S.R., Dinan, T.G., Cryan, J.F., Friends with social benefits: host-microbe interactions as a driver of brain evolution and development?. Front Cell Infect Microbiol, 4, 2014, 147.
61. 61 Alenghat, T., Artis, D., Epigenomic regulation of host-microbiota interactions. Trends Immunol 35 (2014), 518–525.
62. 62 Bourassa, M.W., Alim, I., Bultman, S.J., Ratan, R.R., Butyrate, neuroepigenetics and the gut microbiome: can a high fiber diet improve brain health?. Neurosci Lett 625 (2016), 56–63.
63. 63 Davie, J.R., Inhibition of histone deacetylase activity by butyrate. J Nutr 133 (2003), 2485S–2493S.
64. 64 Arpaia, N., Campbell, C., Fan, X., et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504 (2013), 451–455.
65. 65 Furusawa, Y., Obata, Y., Fukuda, S., et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504 (2013), 446–450.
66. 66 Gao, Z., Yin, J., Zhang, J., et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58 (2009), 1509–1517.
67. 67 Fushimi, T., Suruga, K., Oshima, Y., Fukiharu, M., Tsukamoto, Y., Goda, T., Dietary acetic acid reduces serum cholesterol and triacylglycerols in rats fed a cholesterol-rich diet. Br J Nutr 95 (2006), 916–924.
68. 68 den Besten, G., van Eunen, K., Groen, A.K., Venema, K., Reijngoud, D.J., Bakker, B.M., The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54 (2013), 2325–2340.
69. 69 Hong, Y.H., Nishimura, Y., Hishikawa, D., et al. Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology 146 (2005), 5092–5099.
70. 70 Ge, H., Li, X., Weiszmann, J., et al. Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology 149 (2008), 4519–4526.
71. 71 Suokas, A., Kupari, M., Heikkilä, J., Lindros, K., Ylikahri, R., Acute cardiovascular and metabolic effects of acetate in men. Alcohol Clin Exp Res 12 (1988), 52–58.
72. 72 Al-Lahham, S.H., Peppelenbosch, M.P., Roelofsen, H., Vonk, R.J., Venema, K., Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta 1801 (2010), 1175–1183.
73. 73 Sakakibara, S., Yamauchi, T., Oshima, Y., Tsukamoto, Y., Kadowaki, T., Acetic acid activates hepatic AMPK and reduces hyperglycemia in diabetic KK-A(y) mice. Biochem Biophys Res Commun 344 (2006), 597–604.
74. 74 Maslowski, K.M., Vieira, A.T., Ng, A., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461 (2009), 1282–1286.
75. 75 Frost, G., Sleeth, M.L., Sahuri-Arisoylu, M., et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun, 5, 2014, 3611.
76. 76 Chambers, E.S., Viardot, A., Psichas, A., et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 64 (2015), 1744–1754.
77. 77 Byrne, C.S., Chambers, E.S., Alhabeeb, H., et al. Increased colonic propionate reduces anticipatory reward responses in the human striatum to high-energy foods. Am J Clin Nutr 104 (2016), 5–14.
78. 78 Wall, R., Ross, R.P., Ryan, C.A., et al. Role of gut microbiota in early infant development. Clin Med Pediatr 3 (2009), 45–54.
79. 79 Lyte, M., Probiotics function mechanistically as delivery vehicles for neuroactive compounds: microbial endocrinology in the design and use of probiotics. Bioessays 33 (2011), 574–581.
80. 80 Clarke, G., Grenham, S., Scully, P., et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 18 (2013), 666–673.
81. 81 Heijtz, R.D., Wang, S., Anuar, F., et al. Normal gut microbiota modulates brain development and behaviour. Proc Natl Acad Sci U S A 108 (2011), 3047–3055.
82. 82 Wikoff, W.R., Anfora, A.T., Liu, J., et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A 106 (2009), 3698–3703.
83. 83 El Aidy, S., Kunze, W., Bienenstock, J., Kleerebezem, M., The microbiota and the gut-brain axis: insights from the temporal and spatial mucosal alterations during colonisation of the germfree mouse intestine. Benef Microbes 3 (2012), 251–259.
84. 84 Voreades, N., Kozil, A., Weir, T.L., Diet and the development of the human intestinal microbiome. Front Microbiol, 5, 2014, 494.
85. 85 Salazar, N., Arboleya, S., Valdés, L., et al. The human intestinal microbiome at extreme ages of life. Dietary intervention as a way to counteract alterations. Front Genet, 5, 2014, 406.
86. 86 Canani, R.B., Costanzo, M.D., Leone, L., Epigenetic mechanisms elicited by nutrition in early life. Nutr Res Rev 24 (2011), 198–205.
87. 87 Kerperien, J., Schouten, B., Boehm, G., et al. Development of the immune system-early nutrition and consequences for later life. Recent Advances in Immunology to Target Cancer, Inflammation and Infections. 2012, InTech Europe Press, Rijeka, 315–334.
88. 88 Hinde, K., Lewis, Z.T., MICROBIOTA. Mother's littlest helpers. Science 348 (2015), 1427–1428.
89. 89 Lewis, Z.T., Totten, S.M., Smilowitz, J.T., et al. Maternal fucosyltransferase 2 status affects the gut bifidobacterial communities of breastfed infants. Microbiome, 3, 2015, 13.
90. 90 Kramer, M.S., Kakuma, R., Optimal duration of exclusive breastfeeding. Cochrane Database Syst Rev, 2012, CD003517.
91. 91 Charbonneau, M.R., O'Donnell, D., Blanton, L.V., et al. Sialylated milk oligosaccharides promote microbiota-dependent growth in models of infant Undernutrition. Cell 164 (2016), 859–871.
92. 92 Sela, D.A., Chapman, J., Adeuya, A., et al. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc Natl Acad Sci U S A 105 (2008), 18964–18969.
93. 93 Houghteling, P.D., Walker, W.A., Why is initial bacterial colonization of the intestine important to infants' and children's health?. J Pediatr Gastroenterol Nutr 60 (2015), 294–307.
94. 94 Bezirtzoglou, E., Tsiotsias, A., Welling, G.W., Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH). Anaerobe 17 (2011), 478–482.
95. 95 Guaraldi, F., Salvatori, G., Effect of breast and formula feeding on gut microbiota shaping in newborns. Front Cell Infect Microbiol, 2, 2012, 94.
96. 96 Le Huërou-Luron, I., Blat, S., Boudry, G., Breast- v. formula-feeding: impacts on the digestive tract and immediate and long-term health effects. Nutr Res Rev 23 (2010), 23–36.
97. 97 Pacheco, A.R., Barile, D., Underwood, M.A., Mills, D.A., The impact of the milk Glycobiome on the neonate gut microbiota. Annu Rev Anim Biosci 3 (2015), 419–445.
98. 98 Hill, D.R., Newburg, D.S., Clinical applications of bioactive milk components. Nutr Rev 73 (2015), 463–476.
99. 99 Mugambi, M.N., Musekiwa, A., Lombard, M., Young, T., Blaauw, R., Synbiotics, probiotics or prebiotics in infant formula for full term infants: a systematic review. Nutr J, 4, 2012, 81.
100. 100 Srinivasjois, R., Rao, S., Patole, S., Prebiotic supplementation in preterm neonates: updated systematic review and meta-analysis of randomised controlled trials. Clin Nutr 32 (2013), 958–965.
101. 101 Vandenplas, Y., De Greef, E., Veereman, G., Prebiotics in infant formula. Gut Microbes 5 (2014), 681–687.
102. 102 Fallani, M., Young, D., Scott, J., et al. Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J Pediatr Gastroenterol Nutr 51 (2010), 77–84.
103. 103 Koenig, J.E., Spor, A., Scalfone, N., et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A 108 (2011), 4578–4585.
104. 104 Blanton, L.V., Charbonneau, M.R., Salih, T., et al. Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children. Science, 351, 2016.
105. 105 Falony, G., Joossens, M., Vieira-Silva, S., et al. Population-level analysis of gut microbiome variation. Science 352 (2016), 560–564.
106. 106 O'Toole, P.W., Jeffery, I.B., Gut microbiota and aging. Science 350 (2015), 1214–1215.
107. 107 Claesson, M.J., Cusack, S., O'Sullivan, O., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A 108 (2011), 4586–4591.
108. 108 Woodmansey, E.J., Intestinal bacteria and ageing. J Appl Microbiol 102 (2007), 1178–1186.
109. 109 Lakshminarayanan, B., Stanton, C., O'Toole, P.W., Ross, R.P., Compositional dynamics of the human intestinal microbiota with aging: implications for health. J Nutr Health Aging 18 (2014), 773–786.
110. 110 Ma, J., Prince, A.L., Bader, D., et al. High-fat maternal diet during pregnancy persistently alters the offspring microbiome in a primate model. Nat Commun, 5, 2014, 3889.
111. 111 Li, H., Li, T., Beasley, D.E., et al. Diet diversity is associated with beta but not alpha diversity of Pika gut microbiota. Front Microbiol, 7, 2016, 1169.
112. 112 Albenberg, L.G., Wu, G.D., Diet and the intestinal microbiome: associations, functions, and implications for health and disease. Gastroenterology 146 (2014), 1564–1572.
113. 113 Brown, K., DeCoffe, D., Molcan, E., Gibson, D.L., Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients 4 (2012), 1095–1119.
114. 114 Brinkworth, G.D., Noakes, M., Buckley, J.D., Keogh, J.B., Clifton, P.M., Long-term effects of a very-low-carbohydrate weight loss diet compared with an isocaloric low-fat diet after 12 months. Am J Clin Nutr 90 (2009), 23–32.
115. 115 Russell, W.R., Gratz, S.W., Duncan, H.S., et al. High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr 93 (2011), 1062–1072.
116. 116 Parnell, J.A., Reimer, R.A., Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome. Gut Microbes 3 (2012), 29–34.
117. 117 Myles, I.A., Fast food fever: reviewing the impacts of the Western diet on immunity. Nutr J, 13, 2014, 61.
118. 118 Mizunoya, W., Ohnuki, K., Baba, K., et al. Effect of dietary fat type on anxiety-like and depression-like behavior in mice. Springerplus, 2, 2013, 165.
119. 119 Paik, J., Fierce, Y., Treuting, P.M., Brabb, T., Maggio-Price, L., High-fat diet-induced obesity exacerbates inflammatory bowel disease in genetically susceptible Mdr1a-/- male mice. J Nutr 143 (2013), 1240–1247.
120. 120 Torres-Fuentes, C., Schellekens, H., Dinan, T.G., Cryan, J.F., A natural solution for obesity: bioactives for the prevention and treatment of weight gain. A review. Nutr Neurosci 18 (2015), 49–65.
121. 121 Murphy, E.A., Velazquez, K.T., Herbert, K.M., Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk. Curr Opin Clin Nutr Metab Care 18 (2015), 515–520.
122. 122 Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1031.
123. 123 Turnbaugh, P.J., Ridaura, V.K., Faith, J.J., Rey, F.E., Knight, R., Gordon, J.I., The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med, 1, 2009, 6ra14.
124. 124 Kallus, S.J., Brandt, L.J., The intestinal microbiota and obesity. J Clin Gastroenterol 46 (2012), 16–24.
125. 125 Turnbaugh, P.J., Bäckhed, F., Fulton, L., Gordon, J.I., Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3 (2008), 213–223.
126. 126 Estruch, R., Ros, E., Salas-Salvadó, J., et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368 (2013), 1279–1290.
127. 127 Del Chierico, F., Vernocchi, P., Dallapiccola, B., Putignani, L., Mediterranean diet and health: food effects on gut microbiota and disease control. Int J Mol Sci 15 (2014), 11678–11699.
128. 128 Marlow, G., Ellett, S., Ferguson, I.R., et al. Transcriptomics to study the effect of a Mediterranean-inspired diet on inflammation in Crohn's disease patients. Hum Genomics, 7, 2013, 24.
129. 129 Yamashita, H., Fujisawa, K., Ito, E., et al. Improvement of obesity and glucose tolerance by acetate in Type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Biosci Biotechnol Biochem 71 (2007), 1236–1243.
130. 130 Lin, J., Handschin, C., Spiegelman, B.M., Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1 (2005), 361–370.
131. 131 Jäger, S., Handschin, C., St.-Pierre, J., Spiegelman, B.M., AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α. Proc Natl Acad Sci U S A 104 (2007), 12017–12022.
132. 132 De Filippis, F., Pellegrini, N., Vannini, L., et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut 65 (2015), 1812–1821.
133. 133 Boss, A., Bishop, K.S., Marlow, G., Barnett, M.P., Ferguson, L.R., Evidence to support the Anti-Cancer effect of olive leaf extract and future Directions. Nutrients, 8, 2016.
134. 134 Amel, N., Wafa, T., Samia, D., et al. Extra virgin olive oil modulates brain docosahexaenoic acid level and oxidative damage caused by 2,4-dichlorophenoxyacetic acid in rats. J Food Sci Technol 53 (2016), 1454–1464.
135. 135 Sánchez-Villegas, A., Henríquez, P., Bes-Rastrollo, M., Doreste, J., Mediterranean diet and depression. Public Health Nutr 9 (2006), 1104–1109.
136. 136 Sánchez-Villegas, A., Delgado-Rodríguez, M., Alonso, A., et al. Association of the Mediterranean dietary pattern with the incidence of depression: the Seguimiento Universidad de Navarra/University of Navarra follow-up (SUN) cohort. Arch Gen Psychiatry 66 (2009), 1090–1098.
137. 137 Delgado, P.L., Moreno, F.A., Role of norepinephrine in depression. J Clin Psychiatry 61 (2000), 5–12.
138. 138 Sofi, F., Abbate, R., Gensini, G.F., Casini, A., Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr 92 (2010), 1189–1196.
139. 139 Peng, L., He, Z., Chen, W., Holzman, I.R., Lin, J., Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr Res 61 (2007), 37–41.
140. 140 Wang, L., Christophersen, C.T., Sorich, M.J., Gerber, J.P., Angley, M.T., Conlon, M.A., Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder. Dig Dis Sci 57 (2012), 2096–2102.
141. 141 Plöger, S., Stumpff, F., Penner, G.B., et al. Microbial butyrate and its role for barrier function in the gastrointestinal tract. Ann N Y Acad Sci 1258 (2012), 52–59.
142. 142 Lewis, K., Lutgendorff, F., Phan, V., Söderholm, J.D., Sherman, P.M., McKay, D.M., Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflamm Bowel Dis 16 (2010), 1138–1148.
143. 143 Dvořáková, M., Paduchová, Z., Muchová, J., Duračková, Z., Collins, A.R., How does pycnogenol® influence oxidative damage to DNA and its repair ability in elderly people?. Prague Med Rep 111 (2010), 263–271.
144. 144 Finsterwald, C., Fiumelli, H., Cardinaux, J.R., Martin, J.L., Regulation of dendritic development by BDNF requires activation of CRTC1 by glutamate. J Biol Chem 285 (2010), 28587–28595.
145. 145 Gomez-Pinilla, F., Nguyen, T.T., Natural mood foods: the actions of polyphenols against psychiatric and cognitive disorders. Nutr Neurosci 15 (2012), 127–133.
146. 146 Celik Guzel, E., Bakkal, E., Guzel, S., et al. Can low brain-derived neurotrophic factor levels be a marker of the presence of depression in obese women?. Neuropsychiatr Dis Treat 10 (2014), 2079–2086.
147. 147 Sun, Z.L., Liu, J., Guo, W., et al. Serum brain-derived neurotrophic factor levels associate with cognitive improvement in patients with schizophrenia treated with electroacupuncture. Psychiatry Res 244 (2016), 370–375.
148. 148 Rajilić-Stojanović, M., Function of the microbiota. Best Pract Res Clin Gastroenterol 27 (2013), 5–16.
149. 149 Nicholson, J.K., Holmes, E., Kinross, J., et al. Host-gut microbiota metabolic interactions. Science 336 (2012), 1262–1267.
150. 150 Lyte, M., Chapel, A., Lyte, J.M., et al. Resistant starch alters the microbiota-gut brain axis: implications for dietary modulation of behavior. PLoS One, 11, 2016, e0146406.
151. 151 Sonnenburg, E.D., Smits, S.A., Tikhonov, M., Higginbottom, S.K., Wingreen, N.S., Sonnenburg, J.L., Diet-induced extinctions in the gut microbiota compound over generations. Nature, 529, 2016, 212.
152. 152 Grube, B., Chong, P.W., Lau, K.Z., Orzechowski, H.D., A natural fiber complex reduces body weight in the overweight and obese: a double-blind, randomized, placebo-controlled study. Obesity (Silver Spring) 21 (2013), 58–64.
153. 153 Melanson, K.J., Angelopoulos, T.J., Nguyen, V.T., et al. Consumption of whole-grain cereals during weight loss: effects on dietary quality, dietary fiber, magnesium, vitamin B-6, and obesity. J Am Diet Assoc 106 (2006), 1380–1388.
154. 154 Gann, P.H., Chatterton, R.T., Gapstur, S.M., et al. The effects of a low-fat/high-fiber diet on sex hormone levels and menstrual cycling in premenopausal women: a 12-month randomized trial (the diet and hormone study). Cancer 98 (2003), 1870–1879.
155. 155 Kolida, S., Tuohy, K., Gibson, G.R., Prebiotic effects of inulin and oligofructose. Br J Nutr 87 (2002), S193–S197.
156. 156 Sabater-Molina, M., Larqué, E., Torrella, F., Zamora, S., Dietary fructooligosaccharides and potential benefits on health. J Physiol Biochem 65 (2009), 315–328.
157. 157 Kuo, S.M., The interplay between fiber and the intestinal microbiome in the inflammatory response. Adv Nutr 4 (2013), 16–28.
158. 158 Vandenplas, Y., Oligosaccharides in infant formula. Br J Nutr 87 (2002), S293–S296.
159. 159 Barile, D., Rastall, R.A., Human milk and related oligosaccharides as prebiotics. Curr Opin Biotechnol 24 (2013), 214–219.
160. 160 Ben, X.M., Zhou, X.Y., Zhao, W.H., et al. Supplementation of milk formula with galacto-oligosaccharides improves intestinal micro-flora and fermentation in term infants. Chin Med J (Engl) 117 (2004), 927–931.
161. 161 Garrido, D., Dallas, D.C., Mills, D.A., Consumption of human milk glycoconjugates by infant-associated bifidobacteria: mechanisms and implications. Microbiology 159 (2013), 649–664.
162. 162 Vulevic, J., Juric, A., Walton, G.E., et al. Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons. Br J Nutr 114 (2015), 586–595.
163. 163 Schmidt, K., Cowen, P.J., Harmer, C.J., Tzortzis, G., Errington, S., Burnet, P.W., Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology (Berl) 232 (2015), 1793–1801.
164. 164 Gibson, G.R., Wang, X., Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 77 (1994), 412–420.
165. 165 Ramirez-Farias, C., Slezak, K., Fuller, Z., Duncan, A., Holtrop, G., Louis, P., Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 101 (2009), 541–550.
166. 166 Kruse, H.P., Kleessen, B., Blaut, M., Effects of inulin on faecal bifidobacteria in human subjects. Br J Nutr 82 (1999), 375–382.
167. 167 Videla, S., Vilaseca, J., Antolín, M., Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat. Am J Gastroenterol 96 (2001), 1486–1493.
168. 168 Bouchaud, G., Castan, L., Chesné, J., et al. Maternal exposure to GOS/inulin mixture prevents food allergies and promotes tolerance in offspring in mice. Allergy 71 (2016), 68–76.
169. 169 Maki, K.C., Galant, R., Samuel, P., et al. Effects of consuming foods containing oat beta-glucan on blood pressure, carbohydrate metabolism and biomarkers of oxidative stress in men and women with elevated blood pressure. Eur J Clin Nutr 61 (2007), 786–795.
170. 170 Chan, G.C., Chan, W.K., Sze, D.M., The effects of beta-glucan on human immune and cancer cells. J Hematol Oncol, 2, 2009, 25.
171. 171 Alp, H., Varol, S., Celik, M.M., et al. Protective effects of beta glucan and gliclazide on brain tissue and sciatic nerve of diabetic rats induced by streptozotocin. Exp Diabetes Res, 2012, 2012, 230342.
172. 172 Wu, G.D., Chen, J., Hoffmann, C., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334 (2011), 105–108.
173. 173 Zhao, Y., Wu, J., Li, J.V., Zhou, N.Y., Tang, H., Wang, Y., Gut microbiota composition modifies fecal metabolic profiles in mice. J Proteome Res 12 (2013), 2987–2999.
174. 174 Devkota, S., Wang, Y., Musch, M.W., et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 487 (2012), 104–108.
175. 175 Narushima, S., Itoha, K., Miyamoto, Y., et al. Deoxycholic acid formation in gnotobiotic mice associated with human intestinal bacteria. Lipids 41 (2006), 835–843.
176. 176 Stamp, D.H., Three hypotheses linking bile to carcinogenesis in the gastrointestinal tract: certain bile salts have properties that may be used to complement chemotherapy. Med Hypotheses 59 (2002), 398–405.
177. 177 Duboc, H., Rajca, S., Rainteau, D., et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut 62 (2013), 531–539.
178. 178 Kim, I., Ahn, S.H., Inagaki, T., et al. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res 48 (2007), 2664–2672.
179. 179 Begley, M., Gahan, C.G., Hill, C., The interaction between bacteria and bile. FEMS Microbiol Rev 29 (2005), 625–651.
180. 180 Weingarden, A.R., Chen, C., Bobr, A., et al. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am J Physiol Gastrointest Liver Physiol 306 (2014), G310–G319.
181. 181 Sorg, J.A., Sonenshein, A.L., Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol 190 (2008), 2505–2512.
182. 182 Nie, Y.F., Hu, J., Yan, X.H., Cross-talk between bile acids and intestinal microbiota in host metabolism and health. J Zhejiang Univ Sci B 16 (2015), 436–446.
183. 183 Joyce, S.A., Shanahan, F., Hill, C., Gahan, C.G., Bacterial bile salt hydrolase in host metabolism: potential for influencing gastrointestinal microbe-host crosstalk. Gut Microbes 5 (2014), 669–674.
184. 184 Bu, J., Dou, Y., Tian, X., Wang, Z., Chen, G., The role of omega-3 polyunsaturated fatty acids in stroke. Oxid Med Cell Longev, 2016, 2016, 6906712.
185. 185 Lauritzen, I., Blondeau, N., Heurteaux, C., Widmann, C., Romey, G., Lazdunski, M., Polyunsaturated fatty acids are potent neuroprotectors. EMBO J 19 (2000), 1784–1793.
186. 186 Nobre, M.E., Correia, A.O., Mendonça, F.N., et al. Omega-3 fatty acids: possible neuroprotective mechanisms in the model of global ischemia in rats. J Nutr Metab, 2016, 2016, 6462120.
187. 187 Logan, S.L., Spriet, L.L., Omega-3 fatty acid supplementation for 12 weeks increases resting and exercise metabolic rate in healthy community-dwelling older females. PLoS One, 10, 2015, e0144828.
188. 188 Grosso, G., Galvano, F., Marventano, S., et al. Omega-3 fatty acids and depression: scientific evidence and biological mechanisms. Oxid Med Cell Longev, 2014, 2014, 313570.
189. 189 Chalon, S., Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids 75 (2006), 259–269.
190. 190 Heinrichs, S.C., Dietary omega-3 fatty acid supplementation for optimizing neuronal structure and function. Mol Nutr Food Res 54 (2010), 447–456.
191. 191 Pusceddu, M.M., El Aidy, S., Crispie, F., et al. N-3 polyunsaturated fatty acids (PUFAs) reverse the impact of early-life stress on the gut microbiota. PLoS One, 10, 2015, e0139721.
192. 192 Devillard, E., McIntosh, F.M., Duncan, S.H., Wallace, R.J., Metabolism of linoleic acid by human gut bacteria: different routes for biosynthesis of conjugated linoleic acid. J Bacteriol 189 (2007), 2566–2570.
193. 193 Kaliannan, K., Wang, B., Li, X.Y., Bhan, A.K., Kang, J.X., Omega-3 fatty acids prevent early-life antibiotic exposure-induced gut microbiota dysbiosis and later-life obesity. Int J Obes (Lond) 40 (2016), 1039–1042.
194. 194 Robertson, R.C., Seira Oriach, C., Murphy, K., et al. Omega-3 polyunsaturated fatty acids critically regulate behaviour and gut microbiota development in adolescence and adulthood. Brain Behav Immun, 2016, 1–57.
195. 195 Sarris, J., Murphy, J., Mischoulon, D., et al. Adjunctive nutraceuticals for depression: a systematic review and meta-analyses. Am J Psychiatry 173 (2016), 575–587.
196. 196 LeBlanc, J.G., Milani, C., de Giori, G.S., Sesma, F., van Sinderen, D., Ventura, M., Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol 24 (2013), 160–168.
197. 197 Ivanov, I.I., Atarashi, K., Manel, N., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139 (2009), 485–498.
198. 198 Gaboriau-Routhiau, V., Rakotobe, S., Lécuyer, E., et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31 (2009), 677–689.
199. 199 Bashir, M., Prietl, B., Tauschmann, M., et al. Effects of high doses of vitamin D3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract. Eur J Nutr 55 (2016), 1479–1489.
200. 200 Norton, R., O'Connell, M.A., Vitamin D: Potential in the prevention and treatment of lung cancer. Anticancer Res 32 (2012), 211–221.
201. 201 Fletcher, J.M., Basdeo, S.A., Allen, A.C., Dunne, P.J., Therapeutic use of vitamin D and its analogues in autoimmunity. Recent Pat Inflamm Allergy Drug Discov 6 (2012), 22–34.
202. 202 Valipour, G., Saneei, P., Esmaillzadeh, A., Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies. J Clin Endocrinol Metab 99 (2014), 3863–3872.
203. 203 Sadeghian, M., Saneei, P., Siassi, F., Esmaillzadeh, A., Vitamin D status in relation to Crohn's disease: meta-analysis of observational studies. Nutrition 32 (2016), 505–514.
204. 204 Pereira-Santos, M., Costa, P.R., Assis, A.M., Santos, C.A., Santos, D.B., Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev 16 (2015), 341–349.
205. 205 O'Keefe, S.J., Ou, J., Aufreiter, S., et al. Products of the colonic microbiota mediate the effects of diet on colon cancer risk. J Nutr 139 (2009), 2044–2048.
206. 206 Foxx-Orenstein, A.E., Chey, W.D., Manipulation of the gut microbiota as a novel treatment strategy for gastrointestinal disorders. Am J Gastroenterol Suppl 1 (2012), 41–46.
207. 207 Shenderov, B.A., Metabiotics: novel idea or natural development of probiotic conception. Microb Ecol Health Dis, 12, 2013, 24.
208. 208 Pompei, A., Cordisco, L., Amaretti, A., Zanoni, S., Matteuzzi, D., Rossi, M., Folate production by bifidobacteria as a potential probiotic property. Appl Environ Microbiol 73 (2007), 179–185.
209. 209 Hooper, L.V., Midtvedt, T., Gordon, J.I., How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 22 (2002), 283–307.
210. 210 Pan, L.A., Martin, P., Zimmer, T., et al. Neurometabolic disorders: potentially treatable abnormalities in patients with treatment-refractory depression and suicidal behavior. Am J Psychiatry, 2016, 1–9.
211. 211 Papakostas, G.I., Shelton, R.C., Zajecka, J.M., et al. L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am J Psychiatry 169 (2012), 1267–1274.
212. 212 Owen, R.T., Folate augmentation of antidepressant response. Drugs Today (Barc) 49 (2013), 791–798.
213. 213 Pandey, K.B., Rizvi, S.I., Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev 2 (2009), 270–278.
214. 214 Agouni, A., Lagrue-Lak-Hal, A.H., Mostefai, H.A., et al. Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa). PLoS One, 4, 2009, e5557.
215. 215 Simonyi, A., Wang, Q., Miller, R.L., et al. Polyphenols in cerebral ischemia: novel targets for neuroprotection. Mol Neurobiol 31 (2005), 135–147.
216. 216 Middleton, E. Jr., Kandaswami, C., Theoharides, T.C., The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52 (2000), 673–751.
217. 217 Roopchand, D.E., Carmody, R.N., Kuhn, P., et al. Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high-fat diet-induced metabolic syndrome. Diabetes 64 (2015), 2847–2858.
218. 218 Cardona, F., Andrés-Lacueva, C., Tulipani, S., Tinahones, F.J., Queipo-Ortuño, M.I., Benefits of polyphenols on gut microbiota and implications in human health. J Nutr Biochem 24 (2013), 1415–1422.
219. 219 Kulkarni, S.K., Bhutani, M.K., Bishnoi, M., Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology (Berl) 201 (2008), 435–442.
220. 220 Park, A.J., Collins, J., Blennerhassett, P.A., et al. Altered colonic function and microbiota profile in a mouse model of chronic depression. Neurogastroenterol Motil, 25, 2013 733-e575.
221. 221 Yáñez, M., Fraiz, N., Cano, E., Orallo, F., Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity. Biochem Biophys Res Commun 344 (2006), 688–695.
222. 222 Hurley, L.L., Akinfiresoye, L., Kalejaiye, O., Tizabi, Y., Antidepressant effects of resveratrol in an animal model of depression. Behav Brain Res 268 (2014), 1–7.
223. 223 Zheng, L.T., Ock, J., Kwon, B.M., Suk, K., Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity. Int Immunopharmacol 8 (2008), 484–494.
224. 224 Zhen, L., Zhu, J., Zhao, X., et al. The antidepressant-like effect of fisetin involves the serotonergic and noradrenergic system. Behav Brain Res 228 (2012), 359–366.
225. 225 Magnusson, J., Kull, I., Westman, M., et al. Fish and polyunsaturated fat intake and development of allergic and nonallergic rhinitis. J Allergy Clin Immunol 136 (2015), 1247–1253.
226. 226 Coultrap, S.J., Bickford, P.C., Browning, M.D., Blueberry-enriched diet ameliorates age-related declines in NMDA receptor-dependent LTP. Age (Dordr) 30 (2008), 263–272.
227. 227 Azam, S., Hadi, N., Khan, N.U., Hadi, S.M., Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: implications for anticancer properties. Toxicol In Vitro 18 (2004), 555–561.
228. 228 Chen, Y., Liu, W.H., Chen, B.L., et al. Plant polyphenol curcumin significantly affects CYP1A2 and CYP2A6 activity in healthy, male Chinese volunteers. Ann Pharmacother 44 (2010), 1038–1045.
229. 229 Kuroda, Y., Hara, Y., Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat Res 436 (1999), 69–97.
230. 230 Zhu, W.L., Shi, H.S., Wei, Y.M., et al. Green tea polyphenols produce antidepressant-like effects in adult mice. Pharmacol Res 65 (2012), 74–80.
231. 231 Mazzio, E.A., Harris, N., Soliman, K.F., Food constituents attenuate monoamine oxidase activity and peroxide levels in C6 astrocyte cells. Planta Med 64 (1998), 603–606.
232. 232 Tzounis, X., Vulevic, J., Kuhnle, G.G., et al. Flavanol monomer-induced changes to the human faecal microflora. Br J Nutr 99 (2008), 782–792.
233. 233 Dolara, P., Luceri, C., De Filippo, C., et al. Red wine polyphenols influence carcinogenesis, intestinal microflora, oxidative damage and gene expression profiles of colonic mucosa in F344 rats. Mutat Res 591 (2005), 237–246.
234. 234 Yamakoshi, J., Tokutake, S., Kikuchi, M., Effect of proanthocyanidin- rich extract from grape seeds on human fecal flora and fecal odor. Microb Ecol Health Dis 13 (2001), 25–31.
235. 235 Massot-Cladera, M., Pérez-Berezo, T., Franch, A., Castell, M., Pérez-Cano, F.J., Cocoa modulatory effect on rat faecal microbiota and colonic crosstalk. Arch Biochem Biophys 527 (2012), 105–112.
236. 236 Larrosa, M., Luceri, C., Vivoli, E., et al. Polyphenol metabolites from colonic microbiota exert anti-inflammatory activity on different inflammation models. Mol Nutr Food Res 53 (2009), 1044–1054.
237. 237 Queipo-Ortuño, M.I., Boto-Ordóñez, M., Murri, M., et al. Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am J Clin Nutr 95 (2012), 1323–1334.
238. 238 Xue, B., Xie, J., Huang, J., et al. Plant polyphenols alter a pathway of energy metabolism by inhibiting fecal Bacteroidetes and Firmicutes in vitro. Food Funct 7 (2016), 1501–1507.
239. 239 Greenwood, C.E., Winocur, G., High-fat diets, insulin resistance and declining cognitive function. Neurobiol Aging 26 (2005), 42–45.
240. 240 Parrott, M.D., Greenwood, C.E., Dietary influences on cognitive function with aging: from high-fat diets to healthful eating. Ann N Y Acad Sci 1114 (2007), 389–397.
241. 241 Ferguson, B.J., Marler, S., Altstein, L.L., et al. Associations between cytokines, endocrine stress response, and gastrointestinal symptoms in autism spectrum disorder. Brain Behav Immun 58 (2016), 57–62.
242. 242 Wang, S.S., Kloth, A.D., Badura, A., The cerebellum, sensitive periods, and autism. Neuron 83 (2014), 518–532.
243. 243 Finegold, S.M., Downes, J., Summanen, P.H., Microbiology of regressive autism. Anaerobe 18 (2012), 260–262.
244. 244 Tomova, A., Husarova, V., Lakatosova, S., et al. Gastrointestinal microbiota in children with autism in Slovakia. Physiol Behav 138 (2015), 179–187.
245. 245 Parracho, H.M., Bingham, M.O., Gibson, G.R., McCartney, A.L., Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 54 (2005), 987–991.
246. 246 Kang, D.W., Park, J.G., Ilhan, Z.E., et al. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One, 8, 2013, e68322.
247. 247 Buffington, S.A., Di Prisco, G.V., Auchtung, T.A., Ajami, N.J., Petrosino, J.F., Costa-Mattioli, M., Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell 165 (2016), 1762–1775.
248. 248 De Theije, C.G., Wopereis, H., Ramadan, M., et al. Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav Immun 37 (2014), 197–206.
249. 249 Hsiao, E.Y., McBride, S.W., Hsien, S., et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155 (2013), 1451–1463.
250. 250 Ramirez, P.L., Barnhill, K., Gutierrez, A., Schutte, C., Hewitson, L., Improvements in behavioral symptoms following antibiotic therapy in a 14-year-old male with autism. Case Rep Psychiatry, 2013, 2013, 239034.
251. 251 Ait-Belgnaoui, A., Durand, H., Cartier, C., et al. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology 37 (2012), 1885–1895.
252. 252 Bercik, P., Denou, E., Collins, J., et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141 (2011), 599–609.
253. 253 MacFabe, D.F., Cain, N.E., Boon, F., Ossenkopp, K.P., Cain, D.P., Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: relevance to autism spectrum disorder. Behav Brain Res 217 (2011), 47–54.
254. 254 Thomas, P., Zahorodny, W., Peng, B., et al. The association of autism diagnosis with socioeconomic status. Autism 16 (2012), 201–213.
255. 255 Toh, M.C., Allen-Vercoe, E., The human gut microbiota with reference to autism spectrum disorder: considering the whole as more than a sum of its parts. Microb Ecol Health Dis 28 (2015), 1–6.
256. 256 Son, J.S., Zheng, L.J., Rowehl, L.M., et al. Comparison of fecal microbiota in children with autism spectrum disorders and neurotypical siblings in the Simons Simplex Collection. PLoS One, 10, 2015, e0137725.
257. 257 Srinivasan, P., A review of dietary interventions in autism. Ann Clin Psychiatry 21 (2009), 237–247.
258. 258 Roy, A., Roy, M., Deb, S., et al. Are opioid antagonists effective in attenuating the core symptoms of autism spectrum conditions in children: a systematic review. J Intellect Disabil Res 59 (2015), 293–306.
259. 259 Whiteley, P., Nutritional management of (some) autism: a case for gluten- and casein-free diets?. Proc Nutr Soc 74 (2015), 202–207.
260. 260 Theoharides, T.C., Asadi, S., Patel, A.B., Focal brain inflammation and autism. J Neuroinflammation, 10, 2013, 46.
261. 261 Theoharides, T.C., Angelidou, A., Alysandratos, K.D., et al. Mast cell activation and autism. Biochim Biophys Acta 1822 (2012), 34–41.
262. 262 Tsilioni, I., Taliou, A., Francis, K., Theoharides, T.C., Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6. Transl Psychiatry, 5, 2015, e647.
263. 263 Jang, K.S., Hwang, S.Y., Choi, J.Y., Internet addiction and psychiatric symptoms among Korean adolescents. J Sch Health 78 (2008), 165–171.
264. 264 Parker-Athill, E., Luo, D., Bailey, A., et al. Flavonoids, a prenatal prophylaxis via targeting JAK2/STAT3 signaling to oppose IL-6/MIA associated autism. J Neuroimmunol 217 (2009), 20–27.
265. 265 Klein, M., Berger, S., Hoogman, M., et al. Meta-analysis of the DRD5 VNTR in persistent ADHD. Eur Neuropsychopharmacol 26 (2016), 1527–1532.
266. 266 Graham, J., Banaschewski, T., Buitelaar, J., et al., European Guidelines Group. European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry 20 (2011), 17–37.
267. 267 van de Loo-Neus, G.H., Rommelse, N., Buitelaar, J.K., To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended?. Eur Neuropsychopharmacol 2 (2011), 584–599.
268. 268 Nigg, J.T., Lewis, K., Edinger, T., Falk, M., Meta-analysis of attention-deficit/hyperactivity disorder or attention-deficit/hyperactivity disorder symptoms, restriction diet, and synthetic food color additives. J Am Acad Child Adolesc Psychiatry 51 (2012), 86–97.
269. 269 Arnold, L.E., Alternative treatments for adults with attention-deficit hyperactivity disorder (ADHD). Ann N Y Acad Sci 931 (2001), 310–341.
270. 270 Sonuga-Barke, E.J., Brandeis, D., Cortese, S., et al., European ADHD Guidelines Group. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry 170 (2013), 275–289.
271. 271 Bloch, M.H., Qawasmi, A., Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry 50 (2011), 991–1000.
272. 272 Pelsser, L.M., Frankena, K., Toorman, J., et al. Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): a randomised controlled trial. Lancet 377 (2011), 494–503.
273. 273 Zheng, P., Zeng, B., Zhou, C., et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism. Mol Psychiatry 21 (2016), 786–796.
274. 274 Aizawa, E., Tsuji, H., Asahara, T., et al. Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder. J Affect Disord 202 (2016), 254–257.
275. 275 Bradley, K.A., Case, J.A., Khan, O., et al. The role of the kynurenine pathway in suicidality in adolescent major depressive disorder. Psychiatry Res 227 (2015), 206–212.
276. 276 Kennedy, P.J., Cryan, J.F., Dinan, T.G., Clarke, G., Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology, 2016, 1–48.
277. 277 Romani, L., Zelante, T., De Luca, A., et al. Microbiota control of a tryptophan-AhR pathway in disease tolerance to fungi. Eur J Immunol 44 (2014), 3192–3200.
278. 278 Zelante, T., Iannitti, R.G., Cunha, C., et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39 (2013), 372–385.
279. 279 Zelante, T., Iannitti, R.G., Fallarino, F., et al. Tryptophan feeding of the IDO1-AhR axis in host-microbial symbiosis. Front Immunol, 5, 2014, 640.
280. 280 Miller, A.H., Depression and immunity: a role for T cells?. Brain Behav Immun 24 (2010), 1–8.
281. 281 Pifferi, F., Roux, F., Langelier, B., et al. (n-3) polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter GLUT1 in rats. J Nutr 135 (2005), 2241–2246.
282. 282 Makrides, M., Crowther, C.A., Gibson, R.A., Gibson, R.S., Skeaff, C.M., Docosahexaenoic acid and post-partum depression – is there a link?. Asia Pac J Clin Nutr, 12, 2003, S37.
283. 283 Liperoti, R., Landi, F., Fusco, O., Bernabei, R., Onder, G., Omega-3 polyunsaturated fatty acids and depression: a review of the evidence. Curr Pharm Des 15 (2009), 4165–4172.
284. 284 Sublette, M.E., Ellis, S.P., Geant, A.L., Mann, J.J., Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry 72 (2011), 1577–1584.
285. 285 Young, S.N., Fish oils for depression?. J Psychiatry Neurosci, 33, 2008, 80.
286. 286 Hibbeln, J.R., Fish consumption and major depression. Lancet, 351, 1998, 1213.
287. 287 Hibbeln, J.R., Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord 69 (2002), 15–29.
288. 288 Bourre, J.M., Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J Nutr Health Aging, 8, 2004, 163.
289. 289 Otto, S.J., de Groot, R.H., Hornstra, G., Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. Prostaglandins Leukot Essent Fatty Acids 69 (2003), 237–243.
290. 290 Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., Dinan, T.G., The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res 43 (2008), 164–174.
291. 291 Desbonnet, L., Garrett, L., Clarke, G., Kiely, B., Cryan, J.F., Dinan, T.G., Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 170 (2010), 1179–1188.
292. 292 Wang, S., Blazer, D.G., Depression and cognition in the elderly. Annu Rev Clin Psychol 11 (2015), 331–360.
293. 293 Steenbergen, L., Sellaro, R., van Hemert, S., Bosch, J.A., Colzato, L.S., A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun 48 (2015), 258–264.
294. 294 Savignac, H.M., Kiely, B., Dinan, T.G., Cryan, J.F., Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice. Neurogastroenterol Motil 26 (2014), 1615–1627.
295. 295 Gagliano, H., Delgado-Morales, R., Sanz-Garcia, A., Armario, A., High doses of the histone deacetylase inhibitor sodium butyrate trigger a stress-like response. Neuropharmacology 79 (2014), 75–82.
296. 296 McKnight, P.E., Monfort, S.S., Kashdan, T.B., Blalock, D.V., Calton, J.M., Anxiety symptoms and functional impairment: a systematic review of the correlation between the two measures. Clin Psychol Rev 45 (2016), 115–130.
297. 297 Koen, N., Stein, D.J., Pharmacotherapy of anxiety disorders: a critical review. Dialogues Clin Neurosci 13 (2011), 423–437.
298. 298 Suliman, S., Hemmings, S.M., Seedat, S., Brain-derived neurotrophic factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis. Front Integr Neurosci, 7, 2013, 55.
299. 299 Su, K.P., Matsuoka, Y., Pae, C.U., Omega-3 polyunsaturated fatty acids in prevention of mood and anxiety disorders. Clin Psychopharmacol Neurosci 13 (2015), 129–137.
300. 300 Balanzá-Martínez, V., Fries, G.R., Colpo, G.D., et al. Therapeutic use of omega-3 fatty acids in bipolar disorder. Expert Rev Neurother 11 (2011), 1029–1047.
301. 301 Buydens-Branchey, L., Branchey, M., Hibbeln, J.R., Associations between increases in plasma n-3 polyunsaturated fatty acids following supplementation and decreases in anger and anxiety in substance abusers. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008), 568–575.
302. 302 Dinan, T.G., Cryan, J.F., Microbes, immunity, and behavior: Psychoneuroimmunology Meets the microbiome. Neuropsychopharmacology, 2016, 1–15.